Ideation Challenge: Good Questions Meet Big Data – Up to $10,000 in Prizes
DEADLINE: July 13, 2017 11:59PM
Harvard Catalyst | The Harvard Clinical and Translational Science Center and the Crowd Innovation Laboratory at Harvard Business School invite you to participate in a new ideation challenge.
Challenge: Can you identify a human health problem that might be resolved with big data and a computational solution? Are you working on a problem that could benefit from new algorithmic solutions or improvements? Are you aware of a dataset that could be used to solve this problem or generate further ideas for solutions?
The problem must fall into the clinical and translational research realm. Topics covered might include diagnostics, therapeutics, public health, technology, or outcomes.
Examples:
- Applying human genomic data to solve a scientific challenge
- Using epidemiologic or other data to address a public health issue
- Using image analysis to resolve a diagnostic or therapeutic issue
- Using data available on a government website to resolve a new question
Eligibility: Open to the public.
Process: View the website for more details, and to submit your problem.
Deadline: July 13, 2017 at 11:59pm
Multiple prizes between $500 and $1500 will be awarded, up to $10,000 in total.
View FAQs.
Email us.
Note: You will not be asked to submit a dataset. You will be asked only to briefly define (in three pages or less) a problem that could benefit from a computational answer and characterize the data. In characterizing the data, consider how it might be used for a future ideation challenge related to your question topic. Data can be from your own research or from other private or public sources. This crowd sourcing opportunity is intended to help identify new opportunities as well as difficult “bottleneck” problems that create significant roadblocks to progress in healthcare, translational science, and technological innovation.
The goal of generating these submissions is to provide a basis for developing opportunities that will continue to address important questions through cross-CTSA or local challenges in the near future.